The impact of progestin-based contraceptive initiation on the cervicovaginal proteome and its relationship with HIV acquisition in the ECHO trial

dc.contributor.authorAyele, Hossaena
dc.contributor.examiningcommitteeCoombs, Kevin (Medical Microbiology and Infectious Diseases)en_US
dc.contributor.examiningcommitteeBay, Denice (Medical Microbiology and Infectious Diseases)en_US
dc.contributor.examiningcommitteePoliquin, Vanessa (Obstetrics and Gynecology)en_US
dc.contributor.supervisorBurgener, Adam (Medical Microbiology and Infectious Diseases)en_US
dc.date.accessioned2021-06-25T13:00:08Z
dc.date.available2021-06-25T13:00:08Z
dc.date.copyright2021-06-24
dc.date.issued2021en_US
dc.date.submitted2021-06-24T18:36:51Zen_US
dc.degree.disciplineMedical Microbiology and Infectious Diseasesen_US
dc.degree.levelMaster of Science (M.Sc.)en_US
dc.description.abstractIn sub-Saharan Africa, one of the most popular contraceptives of choice is depo-medroxyprogesterone acetate (DMPA). In many observational studies, DMPA has been associated with an increased acquisition risk of HIV in comparison to other hormonal contraceptives (HC). The recent ECHO (Evidence for Contraceptive options and HIV Outcomes) trial was a clinical trial designed to directly answer the question by randomizing women to three contraceptive types: DMPA-IM (Intramuscular), Copper IUD, and the LNG (Levonorgestrel) Implant. However, this trial found no difference in HIV incidence rates between contraceptive types. Nevertheless, there is an intense debate over concerns regarding the effect of HC’s and DMPA on the mucosal biology of the female genital tract. This thesis is an examination of vaginal mucosal biospecimens from a subset of women who were enrolled in the ECHO trial. Here, we performed mass spectrometry-based proteomic analysis of cervicovaginal soft-cup samples from a subset of women from clinical sites in South Africa and Kenya, for baseline and 1-month post contraception initiation time points, to examine changes to the mucosal proteome and microbiome. Proteome changes associated with DMPA-IM revealed a decrease in proteins involved with innate immune response, with no changes to the vaginal microbiome. Minor changes to the proteome with LNG implant use were observed which precluded pathway analysis. Additionally, no significant changes to the vaginal microbiome were observed. The largest proteome changes were observed with Copper IUD use and included increased immune cell chemotaxis and complement activation, with a decrease in factors relating to cell-cell adhesion and keratinocyte differentiation. The bacterial component of the vaginal microbiome was significantly impacted with Copper IUD use, showing a significant increase in alpha-diversity with a decrease in Lactobacillus and L. iners and an increase in Prevotella and Sneathia species. Additionally, we performed a case-control sub-analysis of women who seroconverted in each contraceptive arm. Proteomic analysis revealed no significant difference to the vaginal microbiome. However, host proteomic signatures associated with cell-cell adhesion were observed to increase amongst HIV seroconverters, which was observed to overlap with signatures identified with Copper IUD use. This research contributes to the discussion on vaginal health and the impact of contraceptives with insight into potential mechanisms associated with HIV incidence.en_US
dc.description.noteOctober 2021en_US
dc.identifier.urihttp://hdl.handle.net/1993/35717
dc.language.isoengen_US
dc.rightsopen accessen_US
dc.subjectDMPAen_US
dc.subjectVaginal microbiomeen_US
dc.subjectProteomicsen_US
dc.subjectHIVen_US
dc.subjectcervicovaginal proteomeen_US
dc.titleThe impact of progestin-based contraceptive initiation on the cervicovaginal proteome and its relationship with HIV acquisition in the ECHO trialen_US
dc.typemaster thesisen_US
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
AyeleH MSc Thesis Final Draft .pdf
Size:
16.96 MB
Format:
Adobe Portable Document Format
Description:
License bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
2.2 KB
Format:
Item-specific license agreed to upon submission
Description: